Antiphospholipid Antibodies: A New Risk Factor for Restenosis After Percutaneous Transluminal Coronary Angioplasty?-Reference-Cited by-同舟云学术

Antiphospholipid Antibodies: A New Risk Factor for Restenosis After Percutaneous Transluminal Coronary Angioplasty?

Published:1998-01 Issue:3 Volume:27 Page:141-148
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Ludia Chiarugi,Domenico Prisco,Monia Capanni,Emilia Antonucci,Sandra Fedi,Agatina Alessandrello Liotta,Massimo Margheri,Cristina Giglioli,Piero Dabizzi Roberto,Ignazio Simonetti,Rosanna Abbate,Franco Gensini Gian

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08916939809003861

Reference39 articles.

1. Cardiac involvement in patients with primary antiphospholipid syndrome

2. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia.

3. Criteria for the Diagnosis of Lupus Anticoagulants: An Update

4. Antiphospholipid-protein antibodies: Laboratory detection and clinical relevance

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Diseases May Increase Adverse Cardiovascular Events After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis;Heart, Lung and Circulation;2019-10

2. Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis;Autoimmunity Reviews;2019-05

3. The Impact of Primary Antiphospholipid Syndrome on Long-term Cardiovascular Outcomes After Percutaneous Coronary Intervention and Stenting in Patients With Myocardial Infarction;JCR: Journal of Clinical Rheumatology;2018-04

4. Impact of Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus on the Long-term Adverse Cardiovascular Outcomes in Patients After Percutaneous Coronary Intervention;Medicine;2016-03

5. Recurrent Stent Thrombosis in a Patient with Antiphospholipid Syndrome and Dual Anti-Platelet Therapy Non-Responsiveness;Korean Circulation Journal;2015